In a report released on October 22, David Evans from Kepler Capital maintained a Buy rating on Novartis AG (NOVN – Research Report), ...

Bank of America Securities analyst Graham Parry reiterated a Hold rating on Novartis AG (NOVN – Research Report) today and set a price ...

The PE firms are up against Dr Reddy's, which has an alliance with Novartis for marketing some of its off-patent products and ...

Brookstone Capital Management trimmed its position in shares of Novartis AG (NYSE:NVS – Free Report) by 1.2% during the third ...

We recently published a list of 10 Wonderful Stocks to Buy Now at a Fair Price. In this article, we are going to take a look ...

On Friday, Novartis AG (NYSE:NVS) announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for ...

A Maryland drug affordability board can move forward with a plan to cap how much the state and local governments pay for ...

If approved, patients in Europe with stage II or III HR+/HER2- early breast cancer (EBC) at high risk of recurrence, including those with node-negative disease, will be eligible for adjuvant treatment ...

BP’s program includes a novel PSMA-binding molecule that may be a potential next-generation radioligand therapy (RLT) for prostate cancer and is currently being studied in two investigator-initiated ...

In this article, we are going to take a look at where Novartis AG (NYSE:NVS) stands against other wonderful stocks to buy now at a fair price. In H2 of the year so far, there are signs that the S ...

The multinational was responding to reports that Alkem was in talks with Novartis AG to acquire the India entity. In fact, NIL stock price ended up over 7 percent on the BSE, at ₹1164.25 ...